Discoid Lupus Erythematosus in Dogs: Welfare Management
Discoid lupus erythematosus (DLE) is an immune-mediated skin condition causing depigmentation, scaling, and ulceration of the nose in dogs — the most common autoimmune skin disease in canine practice.
Key Facts
- DLE is a skin-limited autoimmune condition — unlike systemic lupus it does not affect internal organs
- The nasal planum (nose) is the primary site — depigmentation progresses from grey to pink to raw and ulcerated
- UV light drives disease progression — sun exposure worsens lesions dramatically
- Topical tacrolimus ointment is an effective first-line treatment with minimal systemic effects
- German Shepherds, Siberian Huskies, Collies, and Shetland Sheepdogs have the highest prevalence
Welfare Considerations
DLE causes welfare suffering through nasal pain and ulceration that worsens with sun exposure. Affected noses are hypersensitive — contact with rough surfaces, cold temperatures, and UV all exacerbate discomfort. The condition is not life-threatening but has a significant impact on quality of life if not managed. Sun protection using dog-safe SPF50 sunscreen and management of UV exposure is highly effective at slowing progression. Tacrolimus provides disease control without the systemic side effects of oral immunosuppression, making it the preferred welfare-centered treatment. Complete remission is achievable in many cases.
What You Can Do
- Apply dog-safe SPF50 sunscreen to the nose daily during all sun-exposed periods
- Use topical tacrolimus as directed by your vet — it is very effective with minimal side effects
- Minimize sun exposure during peak UV hours (11am-3pm) for affected dogs
- Monitor for progression from depigmentation to ulceration — worsening warrants veterinary reassessment
- Consider oral immunosuppressive therapy for severe or unresponsive cases after specialist consultation
Learn More About Animal Welfare
Explore our comprehensive resources on animal welfare science, policy, and practice.
Browse All Topics